The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

Share Price Information for Bushveld Minerals (BMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.55
Bid: 0.50
Ask: 0.60
Change: -0.02 (-3.51%)
Spread: 0.10 (20.00%)
Open: 0.575
High: 0.575
Low: 0.525
Prev. Close: 0.57
BMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 of the Takeover Code

2 Feb 2024 14:30

RNS Number : 9141B
Bushveld Minerals Limited
02 February 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Bushveld Minerals Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mustang Energy PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

01/02/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

0.1p ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,880,366

 

15.46

Nill

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

1,880,366

 

15.46

Nill

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

warrants

Details, including nature of the rights concerned and relevant percentages:

636,986

exercise price: £0.30

grant date: 22/11/2023

expiry date: 15/11/2024

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

N/A

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

02/02/2024

Contact name:

Chika Edeh

Telephone number*:

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETEALAAEANLEFA
Date   Source Headline
6th Jul 20239:00 amRNSREPLACEMENT: Posting of Accounts and Notice of AGM
5th Jul 20234:41 pmRNSPosting of Accounts and Notice of General Meeting
30th Jun 20237:00 amRNSPosting of Accounts & Notice of General Meeting
21st Jun 20237:01 amRNSFinal Results for the Year Ended 31 December 2022
21st Jun 20237:00 amRNSBushveld announces appointment of Chief Executive
5th May 20238:00 amRNSProposed convertible loan note refinancing
27th Apr 20237:00 amRNSQ1 2023 Operational Update
12th Apr 20238:00 amRNSAcquisition by VRFB-H of Garnet interest in Enerox
2nd Mar 20234:17 pmRNSPCA Dealing
21st Feb 20237:00 amRNSBELCO update following media report
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSFull Year 2022 Operational Update & 2023 Guidance
16th Dec 20227:00 amRNSDirectorate Change
28th Nov 20228:31 amRNSConditional sale of interest in VRFB-H to Mustang
25th Oct 20227:00 amRNSQ3 2022 and 9M 2022 Operational Update
24th Oct 20225:10 pmRNSInvestor Presentation
10th Oct 20228:32 amRNSMustang Announcement: VRFB-H Investment Update
30th Sep 20227:00 amRNSTotal Voting Rights
20th Sep 20229:05 amRNSSecond Price Monitoring Extn
20th Sep 20229:00 amRNSPrice Monitoring Extension
13th Sep 20224:35 pmRNSIssue of Equity and Convertible Loan Note
13th Sep 20227:00 amRNSInterim Results for Six Months ended 30 June 2022
2nd Sep 20223:36 pmRNSAmendment to Mustang Energy Investment Agreement
31st Aug 20228:35 amRNSTotal Voting Rights
8th Aug 20224:45 pmRNSIssue of Equity and Total Voting Rights
8th Aug 202212:27 pmRNSResult of AGM
28th Jul 20227:00 amRNSQ2 2022 and H1 2022 Operational Update
20th Jul 20224:41 pmRNSSecond Price Monitoring Extn
20th Jul 20224:36 pmRNSPrice Monitoring Extension
13th Jul 20227:00 amRNSPosting of accounts and notice of general meeting
30th Jun 20224:53 pmRNSFinal Results for the Year Ended 31 December 2021
23rd Jun 20227:00 amRNSFunding secured for Vametco hybrid mini-grid
22nd Jun 202210:45 amRNSKey Findings of Vametco and Vanchem Studies
14th Jun 20222:25 pmRNSAppointment of Joint Corporate Broker
10th Jun 202211:50 amRNSVametco signs five-year wage agreement with AMCU
27th May 20227:20 amRNSAppointment of Independent Non-Executive Director
5th May 20224:31 pmRNSHolding(s) in Company
29th Apr 20222:02 pmRNSTotal Voting Rights
26th Apr 20227:00 amRNSQ1 2022 Operational Update
26th Apr 20227:00 amRNSPrimorus Conversion Notice
6th Apr 20227:00 amRNSPrimorus Conversion Notice
4th Apr 20225:09 pmRNSVametco Mineral Resources and Reserves Update
29th Mar 202211:45 amRNSUpdate on the VRFB Holdings Limited - CLN Issue
25th Mar 20229:00 amRNSUpdate on VRFB Holdings Investment
18th Mar 20229:09 amRNSUpdate on the VRFB Holdings Investment by Mustang
17th Mar 20228:17 amRNSAppointment of Independent NEDs and Board Changes
11th Mar 202211:55 amRNSUpdate on the VRFB Holdings Investment by Mustang
7th Mar 20221:22 pmRNSBushveld successfully defends Litigation
10th Feb 20229:24 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.